Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: RNF181 modulates Hippo signaling and triple negative breast cancer progression

Fig. 1

RNF181 is elevated in breast cancer samples and correlated with poor prognosis in triple negative breast cancer cells. ac RNF181 is increased in mRNA expression in breast cancer samples compared with normal breast tissue from different datasets (https://www.oncomine.org). d RNF181 is correlated with poor prognosis in total breast cancer patients (https://kmplot.com). e RNF181 is correlated with poor survival in TNBC patients (https://kmplot.com). f YAP expression level is correlated with poor survival in TNBC patients (https://kmplot.com). g RNF181 is correlated with poor survival in TNBC patients in 5 years follow-up (https://kmplot.com). h RNF181 is correlated with poor survival in TNBC patients in 10 years follow-up (https://kmplot.com)

Back to article page